AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 104 filers reported holding AKERO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,213,204 | +26.6% | 538,023 | +16.9% | 0.01% | +25.0% |
| Q2 2023 | $21,497,430 | +57.1% | 460,429 | +28.7% | 0.00% | +33.3% |
| Q1 2023 | $13,688,165 | -30.7% | 357,767 | -0.7% | 0.00% | -25.0% |
| Q4 2022 | $19,743,180 | +119.2% | 360,277 | +36.2% | 0.00% | +100.0% |
| Q3 2022 | $9,007,000 | +290.1% | 264,510 | +8.3% | 0.00% | – |
| Q2 2022 | $2,309,000 | -31.0% | 244,278 | +3.5% | 0.00% | -100.0% |
| Q1 2022 | $3,347,000 | -36.6% | 235,925 | -5.5% | 0.00% | 0.0% |
| Q4 2021 | $5,283,000 | -4.3% | 249,774 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $5,520,000 | -13.4% | 246,943 | -3.9% | 0.00% | 0.0% |
| Q2 2021 | $6,376,000 | +26.3% | 257,012 | +47.7% | 0.00% | 0.0% |
| Q1 2021 | $5,047,000 | +4.6% | 174,000 | -6.9% | 0.00% | 0.0% |
| Q4 2020 | $4,823,000 | -18.4% | 186,968 | -2.7% | 0.00% | 0.0% |
| Q3 2020 | $5,914,000 | +54.1% | 192,084 | +24.7% | 0.00% | 0.0% |
| Q2 2020 | $3,839,000 | +81.3% | 154,052 | +54.3% | 0.00% | 0.0% |
| Q1 2020 | $2,117,000 | +37.9% | 99,862 | +44.4% | 0.00% | – |
| Q4 2019 | $1,535,000 | -3.5% | 69,161 | -1.1% | 0.00% | – |
| Q3 2019 | $1,590,000 | +632.7% | 69,936 | +517.4% | 0.00% | – |
| Q2 2019 | $217,000 | – | 11,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $179,296 | 57.03% |
| Redmile Group, LLC | 2,632,912 | $144,283,578 | 5.90% |
| Avidity Partners Management LP | 3,825,000 | $209,610,000 | 4.54% |
| COMMODORE CAPITAL LP | 537,076 | $29,432 | 4.44% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $32,564,955 | 3.92% |
| Paradigm Biocapital Advisors LP | 604,544 | $33,129,011 | 3.89% |
| Yiheng Capital Management, L.P. | 1,468,905 | $80,495,994 | 3.56% |
| Altium Capital Management LP | 125,000 | $6,850,000 | 3.48% |
| Tri Locum Partners LP | 128,851 | $7,061,000 | 2.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 172,100 | $9,431,080 | 2.70% |